Vivani Medical, Inc. Files DEF 14A for Annual Meeting and Executive Compensation

Ticker: VANI · Form: DEF 14A · Filed: Apr 29, 2024 · CIK: 1266806

Sentiment: neutral

Topics: DEF 14A, Vivani Medical, Executive Compensation, Annual Meeting, SEC Filing

TL;DR

<b>Vivani Medical, Inc. has filed its DEF 14A, detailing executive compensation and annual meeting information.</b>

AI Summary

Vivani Medical, Inc. (VANI) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Vivani Medical, Inc. filed a DEF 14A with the SEC on April 29, 2024. The filing pertains to the company's annual meeting and executive compensation details. The fiscal year end for Vivani Medical, Inc. is December 31st. The company was formerly known as Second Sight Medical Products Inc. until October 10, 2003. Vivani Medical, Inc. is incorporated in California and operates in the electromedical & electrotherapeutic apparatus industry.

Why It Matters

For investors and stakeholders tracking Vivani Medical, Inc., this filing contains several important signals. This DEF 14A filing provides crucial information for shareholders regarding executive compensation packages and proposals to be voted on at the annual meeting. Understanding the executive compensation structure can offer insights into the company's priorities and its alignment with shareholder interests.

Risk Assessment

Risk Level: low — Vivani Medical, Inc. shows low risk based on this filing. This filing is a routine DEF 14A, primarily disclosing information about executive compensation and annual meeting matters, without indicating immediate financial distress or significant operational shifts.

Analyst Insight

Shareholders should review the disclosed executive compensation details and any proposals for the upcoming annual meeting to make informed voting decisions.

Key Numbers

Key Players & Entities

FAQ

When did Vivani Medical, Inc. file this DEF 14A?

Vivani Medical, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 29, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Vivani Medical, Inc. (VANI).

Where can I read the original DEF 14A filing from Vivani Medical, Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Vivani Medical, Inc..

What are the key takeaways from Vivani Medical, Inc.'s DEF 14A?

Vivani Medical, Inc. filed this DEF 14A on April 29, 2024. Key takeaways: Vivani Medical, Inc. filed a DEF 14A with the SEC on April 29, 2024.. The filing pertains to the company's annual meeting and executive compensation details.. The fiscal year end for Vivani Medical, Inc. is December 31st..

Is Vivani Medical, Inc. a risky investment based on this filing?

Based on this DEF 14A, Vivani Medical, Inc. presents a relatively low-risk profile. This filing is a routine DEF 14A, primarily disclosing information about executive compensation and annual meeting matters, without indicating immediate financial distress or significant operational shifts.

What should investors do after reading Vivani Medical, Inc.'s DEF 14A?

Shareholders should review the disclosed executive compensation details and any proposals for the upcoming annual meeting to make informed voting decisions. The overall sentiment from this filing is neutral.

Filing Stats: 4,965 words · 20 min read · ~17 pages · Grade level 10.9 · Accepted 2024-04-29 16:29:11

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 36 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 38 STOCKHOLDER PROPOSALS 40 STOCKHOLDER MATTERS 41 DELINQUENT SECTION 16(a) REPORTS 42 REPORT OF THE AUDIT COMMITTEE 43 4 THE PROXY PROCEDURE Our board of directors solicits your proxy for the 2024 Annual Meeting of Stockholders (the "Annual Meeting"), and for any postponement or adjournment of the Annual Meeting, for the purposes described in the "Notice of Annual Meeting of Stockholders." The table below shows some important details about the Annual Meeting and voting. Additional information is available in the "About the Annual Meeting: Questions and Answers" section of the proxy statement immediately below the table. We use the terms "Vivani," "the Company," "we," "our" and "us" in this Proxy Statement to refer to Vivani Medical, Inc., a Delaware corporation. This Proxy Statement and the accompanying proxy card are first being delivered, on or about May 15, 2024, to owners of shares of common stock of Vivani Medical, Inc. in connection with the solicitation of proxies by our board of directors ("Board") for our Annual Meeting to be held on June 27, 2024 at 10:00 a.m. Pacific Time online at www.proxydocs.com/VANI. The Annual Meeting will be a completely virtual meeting, which will be conducted via live audio webcast. This proxy procedure permits all stockholders to vote their shares at the Annual Meeting. Our Board encourages you to read this document thoroughly and to take this opportunity to vote on the matters to be decided at the Annual Meeting. Important Notice Regarding the Availability of Proxy Materials for the 2024 Annual Meeting This proxy statement and the 2023 Annual Report are available for viewing, printing and downloading at www.proxydocs.com/VANI and on the "Investors" section of our website at www.vivani.com. Certain documents referenced in the proxy statement are available on our website. However, we are no

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing